脳内炎症制御と核酸治療の二重戦略のためのナノバブル創出と超音波治療システムの構築

• Project/Area Number: 25K03497
• Research Category: Grant-in-Aid for Scientific Research (B)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 90130:Medical systems-related; Basic Section 90140:Medical technology assessment-related; Sections That Are Subject to Joint Review: Basic Section90130:Medical systems-related , Basic Section90140:Medical technology assessment-related
• Research Institution: Tokyo University of Pharmacy and Life Science
• Principal Investigator: 高橋 葉子 (遠藤 葉子) 東京薬科大学, 薬学部, 講師 (30453806)
• Project Period (FY): 2025-04-01 – 2029-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥18,850,000 (Direct Cost: ¥14,500,000、Indirect Cost: ¥4,350,000); Fiscal Year 2028: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000); Fiscal Year 2027: ¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000); Fiscal Year 2026: ¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000); Fiscal Year 2025: ¥5,980,000 (Direct Cost: ¥4,600,000、Indirect Cost: ¥1,380,000)